Development of Itaconate Polymers Microparticles for Intracellular Regulation of Pro‐Inflammatory Macrophage Activation
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202405257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Kaitlyn E Woodworth und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Faculties of Medicine and Engineering, Dalhousie University, Halifax, NS, B3H 4R2, Canada. Hauptthemen laut MEDLINE: Succinates, Macrophages, Microspheres, Macrophage Activation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes for Health Research Project, Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Itaconate (IA) is an endogenous metabolite and a potent regulator of the innate immune system. It's use in immunomodulatory therapies has faced limitations due to challenges in controlled delivery and requirements of high extracellular concentrations for internalization of the highly polar small molecule to achieve its intracellular therapeutic activity. Microparticle (MP)‐based delivery strategies are a promising approach for intracellular delivery of small molecule metabolites through macrophage phagocytosis and subsequent intracellular polymer degradation‐based delivery. Toward the goal of intracellular delivery of IA, degradable polyester polymer‐ (poly(dodecyl itaconate)) based IA polymer microparticles (IA‐MPs) are generated using an emulsion method, forming micron‐scale (≈1.5 µm) degradable microspheres. IA‐MPs are characterized with respect to their material properties and IA release kinetics to inform particle fabrication. Treatment of murine bone marrow‐derived macrophages with an optimized particle concentration of 0.1 mg million −1 cells enables phagocytosis‐mediated internalization and low levels of cytotoxicity. Flow cytometry demonstrates IA‐MP‐specific regulation of IA‐sensitive inflammatory targets. Metabolic analyses demonstrate that IA‐MP internalization inhibits oxidative metabolism and induced glycolytic reliance, consistent with the established mechanism of IA‐associated inhibition of succinate dehydrogenase. This development of IA‐based polymer microparticles provides a basis for additional innovative metabolite‐based microparticle drug delivery systems for the treatment of inflammatory disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Faculties of Medicine and Engineering, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
- Department of Microbiology & Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
- Faculty of Medicine, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
- Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.
- Department of Chemistry, Faculty of Science, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
- Department of Biomaterials & Applied Oral Sciences, Faculty of Dentistry, Dalhousie University, Halifax, NS, B3H 4R2, Canada.
ORCID-Profile: Locke Davenport Huyer
Förderung
- Canadian Institutes for Health Research Project
- Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery
- National Institute of Allergy and Infectious Diseases
- NIAMS NIH HHS
- NIAID NIH HHS
- New Frontiers in Research Fund - Exploration Fund
- NSERC Alliance International Catalyst
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Woodworth, K. E., Froom, Z. S. C. S., Osborne, N. D., Rempe, C. N., Wheeler, B., Medd, K., Callaghan, N. I., Qian, H., Acharya, A. P., Charron, C., & Davenport Huyer, L. (2025). Development of Itaconate Polymers Microparticles for Intracellular Regulation of Pro‐Inflammatory Macrophage Activation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202405257
Vancouver
Woodworth KE, Froom ZSCS, Osborne ND, Rempe CN, Wheeler B, Medd K, et al. Development of Itaconate Polymers Microparticles for Intracellular Regulation of Pro‐Inflammatory Macrophage Activation. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202405257
BibTeX
@article{Woodworth2025,
author = {Woodworth, Kaitlyn E and Froom, Zachary S C S and Osborne, Natasha D and Rempe, Christian N and Wheeler, Brenden and Medd, Kyle and Callaghan, Neal I and Qian, Huikang and Acharya, Abhinav P and Charron, Carlie and Davenport Huyer, Locke},
title = {Development of Itaconate Polymers Microparticles for Intracellular Regulation of Pro‐Inflammatory Macrophage Activation},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202405257}
}
EUVIMED